SCHEMBL92647

SCHEMBL92647

CCCCC(C)CCCNC

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.52
KISS1R Q969F8 1/20 0.39
HTR2A P28223 1/20 0.39
HRH1 P35367 1/20 0.39
ACE2 Q9BYF1 1/20 0.38
LMNA P02545 1/20 0.36
DNM1 Q05193 2/20 0.35
ALDH1A1 P00352 4/20 0.34
TSHR P16473 3/20 0.34
CYP3A4 P08684 1/20 0.34
OPRM1 P35372 1/20 0.33
DPP7 Q9UHL4 1/20 0.31
SLC15A1 P46059 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MAPT P10636 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14616200 1.00 EPHX1 (0.52) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL19198224 0.93 EPHX1 (0.56) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL27334711 0.93 EPHX1 (0.56) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL18758414 0.93 EPHX1 (0.56) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL19427053 0.91 EPHX1 (0.61) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL17808443 0.90 EPHX1 (0.46) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL7026506 0.90 EPHX1 (0.46) EPHX1KISS1RHTR2AHRH1ACE2
SCHEMBL21985348 0.88 EPHX1 (0.64) EPHX1ACE2LMNAALDH1A1TSHR
SCHEMBL24999126 0.86 EPHX1 (0.68) EPHX1ACE2LMNAALDH1A1TSHR
SCHEMBL21084325 0.86 EPHX1 (0.68) EPHX1ACE2LMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024055000-A1 COMPOSITIONS AND METHODS COMPRISING LIPID NANOPARTICLE VACCINES THAT ELICIT A MODULATED IMMUNE RESPONSE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-03-14 WO disclosed
US-20230059865-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2023-02-23 US disclosed
EP-3774843-B1 DIPEPTIDE PIPERIDINE DERIVATIVES MOLECURE SA (PL) 2022-05-25 EP disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 US disclosed
EP-2675819-B1 COMPOSITIONS AND METHODS FOR MOLECULAR LABELING BIO RAD LABORATORIES (US) 2020-04-08 EP disclosed
EP-2961741-B1 NOVEL COMPOUNDS AS DUAL INHIBITORS OF PHOSPHODIESTERASES AND HISTONE DEACETYLASES FUND PARA LA INVESTIG MEDICA APLICADA (ES) 2017-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 EPHX1 4533/4885KISS1R 3978/4885HTR2A 3454/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 EPHX1 4533/4885KISS1R 3978/4885HTR2A 3454/4885
US-20230059865-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SNRPA1 EPHX1 2646/4885KISS1R 4547/4885HTR2A 3545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.